Korro Bio, Inc. (KKR) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q2 26	$1.43	$1.63	+14.0%	—	$5.7B	—
Q1 26	$1.26	$1.39	+10.3%	—	$4.3B	—
Q4 25	$1.14	$1.12	-1.8%	—	$5.7B	—
Q3 25	$1.3	$1.41	+8.5%	—	$5.5B	—
Q2 25	$1.14	$1.18	+3.5%	—	$5B	—
Q1 25	$1.13	$1.15	+1.8%	—	$3.1B	—
Q4 24	$1.28	$1.32	+3.1%	—	$3.2B	—
Q3 24	$1.2	$1.38	+15.0%	—	$4.7B	—
Q2 24	$1.06	$1.09	+2.8%	—	$4.1B	—
Q1 24	$0.95	$0.97	+2.1%	—	$9.6B	—
Q4 23	$0.91	$1	+9.9%	—	$4.4B	—
Q3 23	$0.83	$0.88	+6.0%	—	$3.3B	—
Q2 23	$0.71	$0.73	+2.8%	—	$3.6B	—
Q1 23	$0.74	$0.81	+9.5%	—	$3.1B	—
Q4 22	$0.85	$0.92	+8.2%	—	$2.5B	—
Q3 22	$0.87	$0.93	+6.9%	—	$1.8B	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY25	—	$2.51	—	—	$19.2B	—
FY24	—	$3.47	—	—	$21.6B	—
FY23	—	$4.24	—	—	$14.3B	—
FY22	—	-$0.79	—	—	$5.6B

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	$2B	$3.6B	$2.4B	$4.2B	$4.2B	$16.1B	$5.6B	$14.3B	$21.6B	$19.2B
YoY change	+95.4%	+74.4%	-32.6%	+76.2%	+0.24%	+280.7%	-65.4%	+157.4%	+51.1%	-11.2%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Revenue	2B	3.6B	2.4B	4.2B	4.2B	16.1B	5.6B	14.3B	21.6B	19.2B
Cost of revenue	1.1B	1.7B	1.4B	2.1B	2.2B	9.2B	3.6B	9.5B	17.8B	15.8B
Gross profit	976.2M	1.9B	1B	2.1B	2.1B	6.9B	2B	4.9B	3.8B	3.5B
Gross margin	47.9%	52.3%	42.6%	49.8%	49.1%	42.8%	36.1%	33.9%	17.8%	18%
Research & development	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	631.7M	641.2M	715.1M	791.5M	780.6M	1.9B	2.4B	2.7B	2.9B	3B
Operating expenses	631.7M	641.2M	715.1M	791.5M	780.6M	1.9B	2.4B	2.7B	2.9B	3B
Operating income	344.5M	1.2B	306.4M	1.3B	1.3B	5B	-345.6M	2.1B	926.2M	490.2M
Operating margin	16.9%	34.3%	12.8%	31.1%	30.7%	30.8%	-6.21%	14.9%	4.28%	2.55%
Non-operating income, net	398.8M	1.1B	1.4B	3.5B	4B	8.5B	-204M	4B	4.8B	6.5B
Pretax income	975.2M	2.8B	2.3B	5.2B	5.7B	13.8B	-292.2M	6.6B	5.9B	7.1B
Income tax	24.6M	224.3M	-194.1M	528.8M	609.1M	1.4B	125.4M	1.2B	954.4M	953.7M
Net income	950.7M	2.6B	2.5B	4.6B	5.1B	12.5B	-417.6M	5.4B	4.9B	6.1B
Net margin	46.6%	72%	102.3%	109.9%	121%	77.3%	-7.5%	37.4%	22.7%	32%
EBITDA	1.4B	2.5B	2.9B	2.9B	3B	7.7B	2.5B	5.6B	5.7B	4.2B
EPS	0.64	2.1	2.14	3.62	3.45	7.95	-0.79	4.24	3.47	2.51
Diluted EPS	0.59	1.95	2.06	3.54	3.37	7.42	-0.79	4.09	3.28	2.34

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	3.3B	4.4B	9.6B	4.1B	4.7B	3.2B	3.1B	5B	5.5B	5.7B	4.3B	5.7B
Cost of revenue	1.7B	3.3B	8.6B	3.1B	3.8B	2.3B	3.1B	4B	4.1B	4.5B	3.1B	4.6B
Gross profit	1.6B	1.1B	1B	980.9M	885.6M	948.8M	-84.7M	1.1B	1.3B	1.1B	1.2B	1.1B
Gross margin	49.1%	25.5%	10.7%	23.9%	18.7%	29.6%	-2.77%	21%	24.7%	20.1%	27.7%	18.9%
Research & development	—	—	—	—	—	—	—	—	—	—	—	—
Selling, general & administrative	605.3M	754.9M	684.6M	753.4M	821.6M	656M	622M	725.5M	834.9M	784.1M	419.6M	489.7M
Operating expenses	605.3M	754.9M	684.6M	753.4M	821.6M	656M	622M	725.5M	834.9M	784.1M	721.6M	743.2M
Operating income	1B	361.3M	342M	227.4M	64M	292.7M	-706.7M	327.3M	512.7M	356.9M	456.5M	325.7M
Operating margin	30.6%	8.26%	3.56%	5.54%	1.35%	9.15%	-23.1%	6.54%	9.38%	6.28%	10.7%	5.76%
Non-operating income, net	1.7B	1.4B	939.6M	927.9M	1.5B	1.4B	1.4B	1.2B	1.7B	2.2B	16.9M	1.1B
Pretax income	2.8B	1.9B	1.4B	1.2B	1.6B	1.6B	771.1M	1.5B	2.2B	2.6B	462.9M	1.4B
Income tax	437.2M	286.6M	269.2M	217M	209.9M	258.3M	86.6M	174.3M	359.7M	333.1M	185.4M	246.1M
Net income	2.4B	1.6B	1.1B	993.2M	1.4B	1.4B	684.5M	1.4B	1.8B	2.3B	277.5M	1.1B
Net margin	72.8%	36.3%	11.4%	24.2%	30.3%	43.3%	22.4%	27.1%	33.7%	39.9%	6.53%	19.9%
EBITDA	1.9B	1.6B	1.5B	1.4B	1.1B	1.7B	638.6M	1.3B	1.8B	489.8M	1.7B	1.1B
EPS	1.71	1.18	0.77	0.75	0.68	1.27	-0.22	0.53	0.97	1.24	0.41	0.74
Diluted EPS	1.64	1.14	0.77	0.75	0.64	1.18	-0.22	0.5	0.9	1.16	0.38	0.7

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Market cap	6.9B	9.9B	10.1B	15.9B	22.8B	43.4B	—	—	131.2B	113.5B	86.1B
Enterprise value	21.3B	27.4B	30B	39.9B	49.9B	72.9B	—	—	69.5B	35.3B	147.3B
Shares outstanding	448.9M	468.3M	514.1M	545.1M	562.8M	582.3M	749.5M	867.5M	887M	890.3M	890.3M

Valuation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
P/E	7.27	3.85	4.12	3.43	4.45	3.48	—	—	26.7	18.5	30
P/S	3.39	2.77	4.21	3.77	5.39	2.69	—	—	6.06	5.91	3.35
P/B	0.4	0.48	0.4	0.52	0.56	0.75	—	—	2.12	1.39	2.95
EV/EBITDA	15.6	11.1	10.2	13.7	16.4	9.51	—	—	12.2	8.4	35
EV/Sales	10.5	7.7	12.5	9.45	11.8	4.52	—	—	3.21	1.84	5.7
Earnings yield	13.8%	26%	24.3%	29.2%	22.5%	28.7%	—	—	3.74%	5.41%	3.34%
FCF yield	-21.8%	-36.8%	-76.4%	-37%	-26.8%	-16.8%	—	—	4.96%	0.28%	2.6%
PEG	—	—	—	—	—	—	—	—	—	—	0.76

Profitability

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Gross margin	47.9%	52.3%	42.6%	49.8%	49.1%	42.8%	36.1%	33.9%	17.8%	18%	18.9%
Operating margin	16.9%	34.3%	12.8%	31.1%	30.7%	30.8%	-6.21%	14.9%	4.28%	2.55%	20.6%
Net margin	46.6%	72%	102.3%	109.9%	121%	77.3%	-7.5%	37.4%	22.7%	32%	12.2%
ROE	5.55%	12.4%	9.66%	15.2%	12.5%	21.4%	-0.75%	9.18%	7.91%	7.53%	7.28%
ROA	2.44%	5.59%	4.83%	7.62%	6.41%	4.71%	-0.15%	1.69%	1.36%	1.5%	1.39%
ROIC	1.07%	2.94%	0.68%	2.16%	1.71%	5.08%	-0.4%	2%	318.5%	12.3%	295.3%
Return on tangible assets	2.47%	5.64%	4.85%	7.64%	6.43%	4.79%	-0.16%	1.77%	1.43%	1.57%	1.39%

Financial health

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Current ratio	2.54	1.99	1.97	1.69	2.59	1.29	1.49	1.51	4.12	4.18	0.86
Quick ratio	2.54	1.99	1.97	1.69	2.59	1.29	1.49	1.51	4.12	4.18	3.8
Debt / equity	1.08	1.03	0.88	0.89	0.82	0.68	0.8	0.85	0.82	0.67	0.7
Debt / assets	0.48	0.46	0.44	0.45	0.42	0.15	0.16	0.16	0.14	0.13	0.13
Net debt / EBITDA	10.5	7.11	6.75	8.25	8.91	3.85	12.3	5.22	-10.8	-18.6	-15.9
Interest coverage	2.23	4.44	3.58	5.95	6.9	13.2	0.82	3.22	2.77	3.31	3.14
Effective tax rate	2.52%	8.06%	0%	10.2%	10.6%	10.1%	0%	18.3%	16.3%	13.4%	16.9%

Per share

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Revenue per share	4.54	7.6	4.66	7.74	7.52	27.7	7.42	16.5	24.4	21.6	29
EPS (basic)	0.64	2.1	2.14	3.62	3.45	7.95	-0.79	4.24	3.47	2.51	2.51
EPS (diluted)	0.59	1.95	2.06	3.54	3.37	7.42	-0.79	4.09	3.28	2.34	3.13
Book value per share	38.1	44.1	49.4	56	72.5	99.9	73.9	67.3	69.9	91.7	31.8
FCF per share	-3.35	-7.75	-15	-10.8	-10.9	-12.5	-7.16	-1.85	7.34	0.36	2.47
Cash per share	9.21	7.86	4.76	5.8	11.6	17.3	17.1	23.5	126.9	149.1	53
Capex per share	0.14	0.21	0.15	0.38	0.27	0.18	0.11	0.12	0.16	—	—

Capital allocation

Metric	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	Current
Capex / revenue	3.13%	2.76%	3.28%	4.91%	3.63%	0.63%	1.53%	0.76%	0.65%	—	—
Capex / operating cash flow	-3.4%	-2.34%	-1.22%	-7.28%	-4.38%	-4.43%	-2.03%	-6.92%	3%	—	—
Payout ratio	32.4%	13.5%	14.5%	6.57%	6.91%	3.37%	-122.9%	11.5%	12.5%	12.5%	24%
Dividend yield	4.45%	3.5%	3.52%	1.92%	1.55%	0.97%	—	—	0.47%	0.68%	0.84%

Yield

0.84%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.195

ex-dividend Aug 10, 2026

Payout ratio

24%

of earnings

Dividend growth

5 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Aug 10, 2026	$0.195
May 15, 2026	$0.195
Feb 17, 2026	$0.185

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Revenue	$3.3B	$4.4B	$9.6B	$4.1B	$4.7B	$3.2B	$3.1B	$5B	$5.5B	$5.7B	$4.3B	$5.7B
YoY change	+79.8%	+72.9%	+210.7%	+14.5%	+44.6%	-26.8%	-68.2%	+21.8%	+15.5%	+77.6%	+39.2%	+13.1%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Cash & short-term investments	4.1B	3.7B	2.4B	3.2B	6.5B	10.1B	12.8B	20.3B	112.6B	132.7B
Receivables	49.3M	138.1M	27.3M	26.9M	75.7M	167.7M	167.7M	243.7M	514.6M	487.5M
Inventory	—	—	—	—	—	—	—	—	—	—
Total current assets	6.1B	5.5B	4.2B	4.4B	9B	39.7B	43.6B	61.4B	218.7B	243.4B
Property, plant & equipment	560M	616.6M	676.5M	969.4M	951.4M	1.1B	1.4B	1.4B	1.8B	1.8B
Goodwill & intangibles	448M	425.4M	176.9M	167M	167M	4.6B	10.9B	14.8B	16B	17.6B
Total assets	39B	45.8B	50.7B	60.9B	79.8B	264.3B	275.3B	317.3B	360.1B	410.1B
Accounts payable	1.1B	1.4B	1.1B	1.6B	2B	3.9B	2.1B	2.9B	4.6B	6.6B
Short-term debt	—	—	—	—	—	300.4M	400M	200M	—	—
Total current liabilities	2.4B	2.8B	2.1B	2.6B	3.5B	30.8B	29.3B	40.6B	53.1B	58.2B
Long-term debt	18.5B	21.2B	22.3B	27.1B	33.6B	39.3B	43.7B	49.2B	50.8B	54.5B
Total liabilities	21.9B	25.2B	25.4B	30.4B	39B	206.1B	220B	258.9B	298.1B	328.5B
Shareholders' equity	17.1B	20.7B	25.4B	30.5B	40.8B	58.1B	55.4B	58.4B	62B	81.6B
Total debt	18.5B	21.2B	22.3B	27.1B	33.6B	39.6B	44.1B	49.4B	50.8B	54.5B
Net debt	14.4B	17.5B	19.9B	24B	27.1B	29.5B	31.3B	29B	35.9B	37.6B

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Cash & short-term investments	88B	20.3B	117.6B	114.2B	116.2B	112.6B	118.6B	41.2B	134.1B	132.7B	131.7B	134.9B
Receivables	207.7M	243.7M	287.9M	413M	535.3M	514.6M	475.5M	503.3M	591.6M	487.5M	469.5M	476.8M
Inventory	—	—	—	—	—	—	—	—	—	—	—	—
Total current assets	158.2B	61.4B	210.7B	214.4B	222.6B	218.7B	225.2B	148.2B	241.3B	243.4B	244.4B	242.9B
Property, plant & equipment	1.4B	1.4B	1.4B	1.4B	1.7B	1.8B	1.8B	1.8B	1.8B	1.8B	1.8B	1.9B
Goodwill & intangibles	10.7B	14.8B	15.3B	15.2B	16.1B	16B	16.4B	17B	17.5B	17.6B	18B	19B
Total assets	288.7B	317.3B	339.8B	348.5B	360.7B	360.1B	372.4B	380.9B	398.5B	410.1B	412.1B	414.5B
Accounts payable	2.7B	2.9B	3.8B	4.5B	5.3B	4.6B	5.6B	6.1B	6.4B	6.6B	6.8B	7.8B
Short-term debt	320.3M	200M	—	—	—	—	—	—	—	—	—	—
Total current liabilities	28.7B	40.6B	50.5B	52.2B	54.7B	53.1B	54.8B	54.9B	57.4B	58.2B	62.4B	63.9B
Long-term debt	46.9B	49.2B	49.5B	50.2B	50.5B	50.8B	50.8B	52.5B	54.4B	54.5B	54.6B	55B
Total liabilities	227.1B	258.9B	282.9B	289.9B	298.9B	298.1B	303.4B	309.9B	323.1B	328.5B	331.3B	334B
Shareholders' equity	61.6B	58.4B	56.9B	58.5B	61.8B	62B	69B	71B	75.4B	81.6B	80.8B	80.5B
Total debt	47.2B	49.4B	49.5B	50.2B	50.5B	50.8B	50.8B	52.5B	54.4B	54.5B	54.6B	55B
Net debt	35.9B	29B	33.9B	34.6B	36.1B	35.9B	32.8B	34.7B	31.8B	37.6B	35.4B	33.9B

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY16	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25
Net income	950.7M	2.6B	2.5B	4.6B	5.1B	12.5B	-417.6M	5.4B	4.9B	6.1B
Depreciation & amortization	—	—	—	—	—	—	—	—	—	—
Stock-based compensation	264.9M	334.8M	331.7M	297.7M	326.8M	529.8M	730.2M	618.5M	746.4M	722.1M
Change in working capital	-959.6M	-197.2M	-131.1M	734.5M	-776.9M	96.8M	1.7B	885.9M	-1B	806.3M
Operating cash flow	-1.9B	-4.2B	-6.4B	-2.8B	-3.5B	-2.3B	-4.2B	-1.6B	4.7B	477.8M
Capital expenditure	-63.9M	-98.1M	-78.6M	-207.4M	-153.4M	-102M	-85.1M	-108.4M	-141.5M	—
Investing cash flow	-62.5M	57.7M	-78.6M	-207.4M	-153.4M	-9.6B	-13.6B	-3.9B	-19B	-16.1B
Dividends paid	-307.6M	-345.3M	-355.7M	-304.9M	-353.9M	-419.6M	-513.3M	-615M	-612.1M	-768.5M
Share repurchases	-296.8M	0	-173.1M	-72.1M	-246.2M	-769.7M	-346.7M	-289.8M	0	-3.4M
Financing cash flow	3.1B	3B	6.7B	6.6B	9.9B	20.5B	22.1B	12.8B	7.2B	17.6B
Net change in cash	1.2B	-1.1B	191M	3.5B	6.2B	8.6B	4.3B	7.4B	-7.1B	1.9B
Free cash flow	-1.5B	-3.6B	-7.7B	-5.9B	-6.1B	-7.3B	-5.4B	-1.6B	6.5B	317M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Net income	2.4B	1.6B	1.1B	993.2M	1.4B	1.4B	684.5M	1.4B	1.8B	2.3B	277.5M	1.1B
Depreciation & amortization	—	—	—	—	—	—	—	—	—	—	—	—
Stock-based compensation	146.6M	140.2M	183.4M	184.9M	184.7M	193.5M	183.6M	173.6M	182.2M	182.7M	180.1M	225.9M
Change in working capital	262M	272.2M	346.6M	115.1M	-1.7B	158.9M	119.8M	-863.2M	766.1M	783.6M	175.5M	-506.8M
Operating cash flow	2.6B	1.1B	1.2B	1.7B	504.6M	1.3B	2.5B	438.8M	2.4B	-4.9B	1.7B	3.3B
Capital expenditure	-17.4M	-29.2M	-17.3M	-26.5M	-44.6M	-53.2M	-20.8M	—	—	—	—	—
Investing cash flow	-1.1B	813M	-6.2B	-5.5B	-5.1B	-2.3B	-3.1B	-1.8B	-7B	-4.1B	2.4B	683.4M
Dividends paid	-158.8M	-146M	-146M	-155.3M	-155.3M	-155.4M	-155.4M	-202.5M	-205.2M	-205.3M	-205.2M	-215.5M
Share repurchases	-17.6M	0	—	—	0	0	—	-3.4M	0	0	-191.2M	-42M
Financing cash flow	104.1M	7.2B	45M	2.2B	2.1B	2.9B	3.6B	1.1B	9.4B	3.4B	-1.7B	-2.1B
Net change in cash	1.7B	9.1B	-4.9B	-1.7B	-2.5B	2B	2.9B	-287.1M	4.9B	-5.5B	2.4B	1.9B
Free cash flow	2B	1.1B	1.5B	3.3B	1.8B	-164.8M	2.5B	371.4M	2.4B	-4.9B	1.7B	3.2B

Korro Bio, Inc. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement